AAAAAA

   
Results: 1-16 |
Results: 16
Immunological mechanisms involved in experimental peptide immunotherapy ofT-cell-mediated diseases
Authors: Wauben, MHM
Citation: Mhm. Wauben, Immunological mechanisms involved in experimental peptide immunotherapy ofT-cell-mediated diseases, CR R IMMUN, 20(6), 2000, pp. 451-469
Nasal application of a naturally processed and presented T cell epitope derived from TCR AV11 protects against adjuvant arthritis
Authors: van Tienhoven, EAE Broeren, CPM Noordzij, A Wagenaar, JPA van Eden, W Wauben, MHM
Citation: Eae. Van Tienhoven et al., Nasal application of a naturally processed and presented T cell epitope derived from TCR AV11 protects against adjuvant arthritis, INT IMMUNOL, 12(12), 2000, pp. 1715-1721
'Anergic' T cells modulate the T-cell activating capacity of antigen-presenting cells
Authors: Taams, LS Boot, EPJ van Eden, W Wauben, MHM
Citation: Ls. Taams et al., 'Anergic' T cells modulate the T-cell activating capacity of antigen-presenting cells, J AUTOIMMUN, 14(4), 2000, pp. 335-341
Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes
Authors: van Rensen, AJML Taams, LS Grosfeld-Stulemeyer, MC van Eden, W Crommelin, DJA Wauben, MHM
Citation: Ajml. Van Rensen et al., Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes, PHARM RES, 17(6), 2000, pp. 720-726
Anergic T cells as active regulators of the immune response
Authors: Taams, LS Wauben, MHM
Citation: Ls. Taams et Mhm. Wauben, Anergic T cells as active regulators of the immune response, HUMAN IMMUN, 61(7), 2000, pp. 633-639
Selection of T-cell epitopes from foot-and-mouth disease virus reflects the binding affinity to different cattle MHC class II molecules
Authors: Haghparast, A Wauben, MHM Grosfeld-Stulemeyer, MC van Kooten, P Hensen, EJ
Citation: A. Haghparast et al., Selection of T-cell epitopes from foot-and-mouth disease virus reflects the binding affinity to different cattle MHC class II molecules, IMMUNOGENET, 51(8-9), 2000, pp. 733-742
The efficacy of immunotherapy in an experimental murine model of allergic asthma is related to the strength and site 1 of T cell activation during immunotherapy
Authors: Janssen, EM van Oosterhout, AJM Nijkamp, FP van Eden, W Wauben, MHM
Citation: Em. Janssen et al., The efficacy of immunotherapy in an experimental murine model of allergic asthma is related to the strength and site 1 of T cell activation during immunotherapy, J IMMUNOL, 165(12), 2000, pp. 7207-7214
T cell reactivity to heat shock protein 60 in diabetes-susceptible and genetically protected nonobese diabetic mice is associated with a protective cytokine profile
Authors: van Halteren, AGS Mosselman, B Roep, BO van Eden, W Cooke, A Kraal, G Wauben, MHM
Citation: Ags. Van Halteren et al., T cell reactivity to heat shock protein 60 in diabetes-susceptible and genetically protected nonobese diabetic mice is associated with a protective cytokine profile, J IMMUNOL, 165(10), 2000, pp. 5544-5551
Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: Amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide
Authors: Janssen, EM van Oosterhout, AJM van Rensen, AJML van Eden, W Nijkamp, FP Wauben, MHM
Citation: Em. Janssen et al., Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: Amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide, J IMMUNOL, 164(2), 2000, pp. 580-588
Opposite effects of immunotherapy with ovalbumin and the immunodominant T-cell epitope on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma
Authors: Janssen, EM Wauben, MHM Jonker, EH Hofman, G Van Eden, W Nijkamp, FP van Oosterhout, AJM
Citation: Em. Janssen et al., Opposite effects of immunotherapy with ovalbumin and the immunodominant T-cell epitope on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma, AM J RESP C, 21(1), 1999, pp. 21-29
Liposomes with incorporated MHC class II peptide complexes as antigen presenting vesicles for specific T cell activation
Authors: van Rensen, AJML Wauben, MHM Grosfeld-Stulemeyer, MC van Eden, W Crommelin, DJA
Citation: Ajml. Van Rensen et al., Liposomes with incorporated MHC class II peptide complexes as antigen presenting vesicles for specific T cell activation, PHARM RES, 16(2), 1999, pp. 198-204
Liposomes in autoimmune diseases: selected applications in immunotherapy and inflammation detection
Authors: Crommelin, DJA van Rensen, AJML Wauben, MHM Storm, G
Citation: Dja. Crommelin et al., Liposomes in autoimmune diseases: selected applications in immunotherapy and inflammation detection, J CONTR REL, 62(1-2), 1999, pp. 245-251
Competition for antigenic sites during T cell proliferation: A mathematical interpretation of in vitro data
Authors: Borghans, JAM Taams, LS Wauben, MHM de Boer, RJ
Citation: Jam. Borghans et al., Competition for antigenic sites during T cell proliferation: A mathematical interpretation of in vitro data, P NAS US, 96(19), 1999, pp. 10782-10787
Dose-dependent induction of distinct anergic phenotypes: Multiple levels of T cell anergy
Authors: Taams, LS van Eden, W Wauben, MHM
Citation: Ls. Taams et al., Dose-dependent induction of distinct anergic phenotypes: Multiple levels of T cell anergy, J IMMUNOL, 162(4), 1999, pp. 1974-1981
Critical requirement for aspartic acid at position 82 of myelin basic protein 73-86 for recruitment of V beta 8.2(+) T cells and encephalitogenicity in the Lewis rat
Authors: Smeltz, RB Wauben, MHM Wolf, NA Swanborg, RH
Citation: Rb. Smeltz et al., Critical requirement for aspartic acid at position 82 of myelin basic protein 73-86 for recruitment of V beta 8.2(+) T cells and encephalitogenicity in the Lewis rat, J IMMUNOL, 162(2), 1999, pp. 829-836
Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions
Authors: Taams, LS van Eden, W Wauben, MHM
Citation: Ls. Taams et al., Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions, EUR J IMMUN, 29(5), 1999, pp. 1543-1550
Risultati: 1-16 |